Posthypoxic myoclonus in the rat: Natural history, stability, and serotonergic influences

Movement Disorders

Volumn 15, Issue SUPPL. 1, 2000, Pages 39-46

  Goetz, Christopher G ^a   Vu, Toan Q ^a   Carvey, Paul M ^a   Leurgans, Sue ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN ANTAGONIST;

ANIMAL MODEL; CONFERENCE PAPER; MYOCLONUS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0034101062     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870150708     Document Type: Conference Paper

References (22)

1. Truong DD, Matsumoto RR, Schwartz, PH, Hussong MJ, Wasterlain CG. Novel rat cardiac arrest model of posthypoxic myoclonus. Mov Disord 1994;9:201-206.
2. Matsumoto RR, Aziz N, Truong DD. Association between brain indole levels and severity of posthypoxic myoclonus in rats. Pharmacol Biochem Behav 1995;50:553-558.
3. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963;86: 111-136.
4. Fahn S. Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. Adv Neurol 1979;26:49-105.
5. Pappert EJ, Goetz CG, Vu T, Ling ZD, Carvey PM, Leurgans S. Animal model of Lance-Adams syndrome: time course and natural history. Ann Neurol 1998;44:452.
6. Pappert EJ, Goetz, CG, Vu T, Ling ZD, Leurgans S, Carvey PM. Animal model of post-hypoxic myoclonus: effects of serotonergic antagonists. Neurology 1999;52:16-21.
7. Guilleminault C, Tharp BR, Cousin D. HVA and 5-HIAA CSF measurements and 5-HTP trials in some patients with involuntary movements. J Neurol Sci 1973;18:435-441.
8. Van Woert MH, Rosenbaum D. L-5-hydroxytryptophan therapy in myoclonus. Adv Neurol 1979;26:107-115.
9. Kanthasamy AG, Vu TQ, Truong DD. Neurochemical and behavioral correlates of posthypoxic myoclonus: a microdialysis study [Abstract]. Society for Neurosci Abstracts 1995;21:2058.
10. 1A receptors in vivo. Eur J Pharmacol 1993;240:307-310.
11. IC/2 receptor agonists and antagonists. Eur J Pharmacol 1993;244:1-5.
12. 1C receptor subtype. Neurosci Lett 1989;105:174-176.
13. 1D receptor antagonist on brain 5-HT metabolism. Neuropharmacology 1995;34:383-392.
14. 2 receptor antagonist. J Pharmacol Exp Ther 1992;262:759-768.
15. Costall B, Jones BJ, Kelly ME. The effects of ondansetron in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 1989;34:769-778.
16. 4 receptors improve social olfactory memory in the rat. Neuropharmacology 1997;36:681-687.
17. Truong DD, Galloway MP. Pezzoli G. Milacemide increases 5HT and dopamine levels in rat brain - possible mechanisms of milacemide antimyoclonic property in the p.p′-DTT-induced myoclonus model. Mov Disord 1994;9:201-206.
18. 1/2 receptor subtypes. Eur J Pharmacol 1998;347:51-56.
19. Fleshier M. Adequate acoustic stimulus for startle reaction in the rat. J Comp. Physiol Psychol 1965;60:200-207.
20. Castaigne P, Cambier J, Escuurolle R, Cathala HP, Lacasble R. Observation anatomo-clinique d'un syndrome myoclonique postanoxique. Rev Neurol (Paris) 1964;111:60-73.
21. 2c receptors is a primary receptor in the basal ganglia. J Neurochem 1997;69:1449-1458.
22. Nagata T. Techniques and applications of microsurgical radioautography. Histol Histopathol 1997;12:1091-1124.